InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Frenkel Ran, Vice-Président Exécutif. Officer active across 1 company, notably Karyopharm Therapeutics Inc.. In total, 3 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €48k. History available since 7 February 2022. The latest transaction was disclosed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Frenkel Ran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
68,250 shares0Common StockSEC:0001209191-22-014629:0
2,929 shares@ US$12.123464.6% of flowCommon StockSEC:0001209191-22-011643:0
1,991 shares@ US$9.86235.4% of flowCommon StockSEC:0001209191-22-008128:0
3 of 3 declarations
About Frenkel Ran
Ran Frenkel is the Executive Vice President and Chief Development Officer at Karyopharm Therapeutics Inc. He is responsible for strategic development and innovation within the company. His role is essential in positioning Karyopharm as a leader in the biopharmaceutical sector.
